There is an urgent need for a multifaceted solution that encompasses a comprehensive roadmap for both development and commercialization of novel antibiotics. Here, uptake and reimbursement pose challenges for new antibiotics.
New Antibiotics Face Major Development And Reimbursement Hurdles
